Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intensive Care Units | 60 | 2021 | 3731 | 3.090 |
Why?
|
Critical Care | 30 | 2020 | 2697 | 2.310 |
Why?
|
Critical Illness | 34 | 2020 | 2707 | 2.220 |
Why?
|
Hospital Mortality | 32 | 2020 | 5414 | 2.080 |
Why?
|
Patient Admission | 10 | 2020 | 1383 | 1.860 |
Why?
|
Medical Informatics | 9 | 2020 | 732 | 1.710 |
Why?
|
Sepsis | 18 | 2020 | 2594 | 1.500 |
Why?
|
Artificial Intelligence | 11 | 2020 | 2532 | 1.390 |
Why?
|
Respiration, Artificial | 11 | 2019 | 2616 | 1.310 |
Why?
|
Delivery of Health Care | 10 | 2020 | 5317 | 1.260 |
Why?
|
Databases, Factual | 26 | 2020 | 8000 | 1.150 |
Why?
|
Biomedical Research | 9 | 2020 | 3416 | 0.990 |
Why?
|
Triage | 3 | 2020 | 982 | 0.860 |
Why?
|
Information Dissemination | 3 | 2020 | 1132 | 0.740 |
Why?
|
Electronic Health Records | 9 | 2020 | 4737 | 0.700 |
Why?
|
Data Mining | 5 | 2018 | 550 | 0.690 |
Why?
|
Minority Health | 1 | 2020 | 80 | 0.670 |
Why?
|
Public Health Informatics | 1 | 2020 | 109 | 0.660 |
Why?
|
Humanities | 1 | 2019 | 54 | 0.650 |
Why?
|
Appointments and Schedules | 2 | 2020 | 437 | 0.640 |
Why?
|
Third-Party Consent | 1 | 2018 | 66 | 0.610 |
Why?
|
Length of Stay | 10 | 2019 | 6452 | 0.600 |
Why?
|
Coronavirus | 1 | 2020 | 149 | 0.590 |
Why?
|
Monitoring, Physiologic | 5 | 2018 | 1783 | 0.580 |
Why?
|
Diltiazem | 1 | 2017 | 131 | 0.570 |
Why?
|
Metoprolol | 1 | 2017 | 92 | 0.570 |
Why?
|
Central Venous Pressure | 2 | 2016 | 79 | 0.570 |
Why?
|
Cooperative Behavior | 6 | 2018 | 1501 | 0.550 |
Why?
|
Patient Transfer | 3 | 2018 | 775 | 0.540 |
Why?
|
Forecasting | 3 | 2020 | 2931 | 0.530 |
Why?
|
Zinc | 1 | 2020 | 688 | 0.530 |
Why?
|
Magnesium | 3 | 2015 | 810 | 0.530 |
Why?
|
Amiodarone | 1 | 2017 | 218 | 0.520 |
Why?
|
Hospitals, Teaching | 6 | 2018 | 1166 | 0.520 |
Why?
|
Peer Review, Research | 2 | 2019 | 341 | 0.510 |
Why?
|
Natural Language Processing | 3 | 2020 | 1128 | 0.510 |
Why?
|
Decision Support Systems, Clinical | 5 | 2020 | 1161 | 0.500 |
Why?
|
Advanced Cardiac Life Support | 1 | 2015 | 78 | 0.500 |
Why?
|
Edema | 2 | 2016 | 772 | 0.490 |
Why?
|
Humans | 149 | 2021 | 759255 | 0.490 |
Why?
|
Retrospective Studies | 52 | 2020 | 80121 | 0.480 |
Why?
|
Aged | 69 | 2020 | 168617 | 0.480 |
Why?
|
Information Management | 1 | 2014 | 100 | 0.460 |
Why?
|
Drug Dosage Calculations | 1 | 2014 | 118 | 0.460 |
Why?
|
Deep Sedation | 1 | 2015 | 117 | 0.450 |
Why?
|
Vasoconstrictor Agents | 7 | 2019 | 651 | 0.440 |
Why?
|
Aged, 80 and over | 38 | 2020 | 58867 | 0.440 |
Why?
|
Palliative Care | 5 | 2017 | 3606 | 0.430 |
Why?
|
Siblings | 1 | 2017 | 825 | 0.430 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2016 | 403 | 0.430 |
Why?
|
Knowledge | 1 | 2014 | 176 | 0.430 |
Why?
|
Hypoglycemia | 1 | 2020 | 883 | 0.430 |
Why?
|
Male | 90 | 2020 | 358719 | 0.420 |
Why?
|
Norepinephrine | 2 | 2018 | 899 | 0.410 |
Why?
|
Telemedicine | 7 | 2019 | 2998 | 0.410 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 3207 | 0.410 |
Why?
|
Learning | 3 | 2018 | 1729 | 0.410 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 3 | 2009 | 33 | 0.410 |
Why?
|
Middle Aged | 69 | 2020 | 219653 | 0.400 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1395 | 0.400 |
Why?
|
Catheterization, Peripheral | 1 | 2015 | 343 | 0.400 |
Why?
|
Urban Population | 1 | 2020 | 2015 | 0.400 |
Why?
|
Female | 89 | 2020 | 390240 | 0.390 |
Why?
|
Kidney Failure, Chronic | 3 | 2020 | 2469 | 0.390 |
Why?
|
Logistic Models | 13 | 2020 | 13309 | 0.390 |
Why?
|
Hyperglycemia | 1 | 2020 | 1378 | 0.390 |
Why?
|
New Zealand | 7 | 2013 | 354 | 0.380 |
Why?
|
Influenza, Human | 4 | 2017 | 1533 | 0.380 |
Why?
|
Severity of Illness Index | 18 | 2020 | 15815 | 0.380 |
Why?
|
Capacity Building | 1 | 2013 | 258 | 0.370 |
Why?
|
Medicine | 1 | 2019 | 943 | 0.370 |
Why?
|
Terminal Care | 4 | 2019 | 1757 | 0.370 |
Why?
|
Software | 5 | 2018 | 4421 | 0.370 |
Why?
|
Resuscitation Orders | 4 | 2020 | 270 | 0.370 |
Why?
|
Conscious Sedation | 1 | 2015 | 529 | 0.360 |
Why?
|
Troponin | 1 | 2014 | 515 | 0.360 |
Why?
|
Portugal | 2 | 2020 | 90 | 0.350 |
Why?
|
Mortality | 2 | 2019 | 2914 | 0.350 |
Why?
|
Algorithms | 12 | 2020 | 13946 | 0.340 |
Why?
|
Home Care Services | 1 | 2016 | 649 | 0.340 |
Why?
|
Coronary Artery Bypass | 1 | 2019 | 2274 | 0.340 |
Why?
|
Erythrocyte Transfusion | 1 | 2014 | 564 | 0.340 |
Why?
|
Voluntary Programs | 1 | 2009 | 48 | 0.330 |
Why?
|
Fluid Therapy | 2 | 2013 | 592 | 0.320 |
Why?
|
Atrial Fibrillation | 3 | 2018 | 5198 | 0.320 |
Why?
|
Hospitalization | 9 | 2021 | 10734 | 0.320 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2016 | 1032 | 0.320 |
Why?
|
Language | 1 | 2018 | 1525 | 0.310 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2015 | 1001 | 0.310 |
Why?
|
Medical Records Systems, Computerized | 1 | 2014 | 1192 | 0.310 |
Why?
|
Patient Preference | 1 | 2015 | 919 | 0.310 |
Why?
|
Pandemics | 4 | 2020 | 8609 | 0.310 |
Why?
|
Vaccination | 3 | 2009 | 3354 | 0.300 |
Why?
|
Hemothorax | 1 | 2007 | 57 | 0.290 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3150 | 0.290 |
Why?
|
Quality of Health Care | 4 | 2018 | 4359 | 0.280 |
Why?
|
Acute Kidney Injury | 6 | 2016 | 1935 | 0.280 |
Why?
|
Mammary Arteries | 1 | 2007 | 81 | 0.280 |
Why?
|
Respiratory Insufficiency | 1 | 2015 | 1225 | 0.280 |
Why?
|
Heparin | 1 | 2014 | 1656 | 0.280 |
Why?
|
Public Health | 1 | 2020 | 2654 | 0.280 |
Why?
|
Risk Assessment | 10 | 2020 | 24049 | 0.270 |
Why?
|
Echocardiography | 2 | 2018 | 4971 | 0.270 |
Why?
|
United States | 25 | 2020 | 72237 | 0.260 |
Why?
|
Blood Glucose | 1 | 2020 | 6368 | 0.260 |
Why?
|
Insulin | 1 | 2020 | 6591 | 0.260 |
Why?
|
Cross Infection | 2 | 2011 | 1434 | 0.250 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3087 | 0.250 |
Why?
|
Data Collection | 1 | 2015 | 3317 | 0.250 |
Why?
|
Insurance Coverage | 1 | 2017 | 1939 | 0.250 |
Why?
|
Liver Cirrhosis | 3 | 2020 | 1925 | 0.250 |
Why?
|
Age Factors | 8 | 2018 | 18394 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3207 | 0.250 |
Why?
|
Proton Pump Inhibitors | 3 | 2016 | 552 | 0.250 |
Why?
|
Pheochromocytoma | 1 | 2007 | 328 | 0.250 |
Why?
|
Water-Electrolyte Imbalance | 2 | 2017 | 110 | 0.250 |
Why?
|
Carbon Dioxide | 5 | 2010 | 1144 | 0.250 |
Why?
|
Hypotension | 3 | 2016 | 882 | 0.250 |
Why?
|
Internet | 2 | 2016 | 3073 | 0.240 |
Why?
|
Referral and Consultation | 4 | 2017 | 3598 | 0.240 |
Why?
|
Stroke Volume | 2 | 2015 | 5497 | 0.240 |
Why?
|
Models, Statistical | 4 | 2020 | 5066 | 0.240 |
Why?
|
Insurance, Health | 1 | 2017 | 2500 | 0.240 |
Why?
|
Ozone | 2 | 2018 | 477 | 0.230 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2015 | 2128 | 0.230 |
Why?
|
Propensity Score | 3 | 2018 | 1915 | 0.230 |
Why?
|
Risk Factors | 24 | 2020 | 74167 | 0.230 |
Why?
|
Liver Failure | 2 | 2017 | 249 | 0.220 |
Why?
|
Influenza Vaccines | 2 | 2008 | 770 | 0.220 |
Why?
|
Heart Failure | 6 | 2018 | 11833 | 0.220 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2940 | 0.210 |
Why?
|
Pneumonia | 4 | 2021 | 2138 | 0.210 |
Why?
|
Endovascular Procedures | 1 | 2016 | 2137 | 0.210 |
Why?
|
Adult | 40 | 2020 | 219390 | 0.200 |
Why?
|
Neurofibromatosis 1 | 1 | 2007 | 561 | 0.200 |
Why?
|
Aneurysm, Ruptured | 1 | 2007 | 456 | 0.200 |
Why?
|
Interdisciplinary Communication | 3 | 2018 | 934 | 0.200 |
Why?
|
Health Personnel | 3 | 2018 | 3309 | 0.200 |
Why?
|
Odds Ratio | 8 | 2020 | 9711 | 0.200 |
Why?
|
Longitudinal Studies | 8 | 2020 | 14442 | 0.200 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2007 | 734 | 0.200 |
Why?
|
Survival Rate | 5 | 2020 | 12800 | 0.200 |
Why?
|
Patient Readmission | 4 | 2020 | 3323 | 0.200 |
Why?
|
Access to Information | 3 | 2020 | 320 | 0.190 |
Why?
|
Communication | 1 | 2015 | 3846 | 0.190 |
Why?
|
Healthcare Disparities | 2 | 2018 | 3368 | 0.190 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2017 | 499 | 0.190 |
Why?
|
Sodium | 2 | 2017 | 1601 | 0.190 |
Why?
|
ROC Curve | 5 | 2020 | 3570 | 0.190 |
Why?
|
Blood Pressure | 5 | 2018 | 8523 | 0.180 |
Why?
|
Occupational Diseases | 1 | 2009 | 1484 | 0.180 |
Why?
|
Hypercapnia | 4 | 2010 | 261 | 0.180 |
Why?
|
Health Services Accessibility | 3 | 2018 | 5377 | 0.180 |
Why?
|
Wounds and Injuries | 1 | 2013 | 2477 | 0.180 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4006 | 0.180 |
Why?
|
Phenotype | 1 | 2018 | 16532 | 0.170 |
Why?
|
Prognosis | 12 | 2020 | 29561 | 0.170 |
Why?
|
Nurses | 1 | 2009 | 2466 | 0.170 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2020 | 1132 | 0.160 |
Why?
|
Arrhythmias, Cardiac | 3 | 2019 | 2253 | 0.160 |
Why?
|
Cardiac Complexes, Premature | 1 | 2018 | 63 | 0.160 |
Why?
|
Body Surface Area | 1 | 2019 | 197 | 0.160 |
Why?
|
Cerebrovascular Circulation | 5 | 2010 | 2725 | 0.160 |
Why?
|
Antidiuretic Agents | 1 | 2018 | 21 | 0.160 |
Why?
|
Physicians | 1 | 2017 | 4586 | 0.160 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2020 | 94 | 0.160 |
Why?
|
Anticoagulants | 1 | 2014 | 4897 | 0.160 |
Why?
|
Treatment Outcome | 7 | 2020 | 64879 | 0.160 |
Why?
|
Reproducibility of Results | 6 | 2019 | 20031 | 0.160 |
Why?
|
APACHE | 1 | 2019 | 267 | 0.160 |
Why?
|
Time Factors | 13 | 2020 | 40109 | 0.160 |
Why?
|
Candidiasis | 1 | 2011 | 363 | 0.160 |
Why?
|
Models, Theoretical | 5 | 2017 | 3556 | 0.150 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7460 | 0.150 |
Why?
|
Bed Occupancy | 1 | 2018 | 38 | 0.150 |
Why?
|
Hypokalemia | 1 | 2019 | 153 | 0.150 |
Why?
|
Abdomen | 1 | 2014 | 1121 | 0.150 |
Why?
|
Cohort Studies | 15 | 2020 | 41247 | 0.150 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 1 | 2018 | 85 | 0.150 |
Why?
|
Computer Security | 1 | 2020 | 260 | 0.150 |
Why?
|
Stroke | 1 | 2020 | 9935 | 0.150 |
Why?
|
Esophageal and Gastric Varices | 1 | 2020 | 208 | 0.150 |
Why?
|
Postoperative Period | 2 | 2019 | 1823 | 0.140 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6813 | 0.140 |
Why?
|
Embolism, Amniotic Fluid | 1 | 2017 | 20 | 0.140 |
Why?
|
Income | 2 | 2017 | 1876 | 0.140 |
Why?
|
Puerperal Infection | 1 | 2017 | 44 | 0.140 |
Why?
|
Renal Dialysis | 2 | 2017 | 1802 | 0.140 |
Why?
|
Information Storage and Retrieval | 2 | 2016 | 821 | 0.140 |
Why?
|
Vasopressins | 1 | 2018 | 355 | 0.140 |
Why?
|
Hypocapnia | 4 | 2010 | 38 | 0.140 |
Why?
|
Boston | 6 | 2019 | 9274 | 0.140 |
Why?
|
Dialysis Solutions | 1 | 2016 | 33 | 0.140 |
Why?
|
Health Facility Size | 1 | 2016 | 62 | 0.140 |
Why?
|
Histamine H2 Antagonists | 2 | 2015 | 167 | 0.140 |
Why?
|
Blood Gas Analysis | 2 | 2015 | 378 | 0.140 |
Why?
|
Water-Electrolyte Balance | 2 | 2015 | 334 | 0.140 |
Why?
|
Regression Analysis | 2 | 2018 | 6359 | 0.140 |
Why?
|
Hospitals | 2 | 2020 | 3930 | 0.140 |
Why?
|
Databases as Topic | 2 | 2016 | 474 | 0.140 |
Why?
|
Withholding Treatment | 2 | 2019 | 612 | 0.130 |
Why?
|
Body Weight | 2 | 2019 | 4608 | 0.130 |
Why?
|
Systole | 1 | 2018 | 947 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2014 | 1403 | 0.130 |
Why?
|
Particulate Matter | 2 | 2018 | 2557 | 0.130 |
Why?
|
Renal Replacement Therapy | 1 | 2018 | 281 | 0.130 |
Why?
|
Tidal Volume | 1 | 2018 | 485 | 0.130 |
Why?
|
Community Health Services | 2 | 2018 | 653 | 0.130 |
Why?
|
Fuzzy Logic | 1 | 2015 | 57 | 0.130 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12152 | 0.130 |
Why?
|
Lactic Acid | 2 | 2018 | 1132 | 0.130 |
Why?
|
Health Services Research | 2 | 2020 | 1809 | 0.130 |
Why?
|
Patient Discharge | 2 | 2018 | 3460 | 0.120 |
Why?
|
Family Characteristics | 1 | 2020 | 1001 | 0.120 |
Why?
|
Publication Bias | 1 | 2016 | 162 | 0.120 |
Why?
|
After-Hours Care | 1 | 2016 | 101 | 0.120 |
Why?
|
Potassium | 1 | 2019 | 1318 | 0.120 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2019 | 782 | 0.120 |
Why?
|
Hospitals, Rural | 1 | 2016 | 175 | 0.120 |
Why?
|
Middle Cerebral Artery | 4 | 2010 | 274 | 0.120 |
Why?
|
National Health Programs | 1 | 2018 | 442 | 0.120 |
Why?
|
Decision Support Techniques | 2 | 2016 | 1999 | 0.120 |
Why?
|
Hospitals, Urban | 1 | 2016 | 499 | 0.120 |
Why?
|
Health Services Misuse | 1 | 2016 | 245 | 0.120 |
Why?
|
Injury Severity Score | 1 | 2018 | 1036 | 0.120 |
Why?
|
Magnesium Deficiency | 1 | 2014 | 48 | 0.110 |
Why?
|
Body Mass Index | 4 | 2019 | 12874 | 0.110 |
Why?
|
Air Pollution | 2 | 2018 | 2316 | 0.110 |
Why?
|
Ophthalmology | 1 | 2020 | 547 | 0.110 |
Why?
|
China | 1 | 2020 | 2347 | 0.110 |
Why?
|
Problem Solving | 1 | 2016 | 440 | 0.110 |
Why?
|
Partial Thromboplastin Time | 1 | 2014 | 206 | 0.110 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2015 | 150 | 0.110 |
Why?
|
Area Under Curve | 4 | 2018 | 1634 | 0.110 |
Why?
|
Pulmonary Edema | 1 | 2016 | 409 | 0.110 |
Why?
|
Catheters, Indwelling | 1 | 2015 | 429 | 0.110 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2017 | 1128 | 0.110 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2018 | 615 | 0.110 |
Why?
|
Lymphocyte Count | 1 | 2015 | 779 | 0.100 |
Why?
|
Minority Groups | 1 | 2020 | 1198 | 0.100 |
Why?
|
Acidosis, Lactic | 1 | 2014 | 145 | 0.100 |
Why?
|
Health Services | 1 | 2018 | 754 | 0.100 |
Why?
|
Sex Factors | 3 | 2018 | 10518 | 0.100 |
Why?
|
Review Literature as Topic | 1 | 2014 | 339 | 0.100 |
Why?
|
Personal Satisfaction | 1 | 2017 | 642 | 0.100 |
Why?
|
Treatment Failure | 1 | 2018 | 2642 | 0.100 |
Why?
|
Feedback, Physiological | 1 | 2015 | 476 | 0.100 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2016 | 498 | 0.100 |
Why?
|
Pain Measurement | 2 | 2019 | 3512 | 0.100 |
Why?
|
Informed Consent | 1 | 2018 | 1008 | 0.100 |
Why?
|
Hemodynamics | 3 | 2018 | 4164 | 0.100 |
Why?
|
Erythrocyte Indices | 1 | 2012 | 145 | 0.100 |
Why?
|
Unemployment | 1 | 2013 | 210 | 0.100 |
Why?
|
Obesity | 4 | 2019 | 12896 | 0.090 |
Why?
|
Attitude of Health Personnel | 3 | 2017 | 3863 | 0.090 |
Why?
|
Fibrosis | 1 | 2018 | 2041 | 0.090 |
Why?
|
Renal Insufficiency | 1 | 2017 | 820 | 0.090 |
Why?
|
Comorbidity | 6 | 2018 | 10547 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1758 | 0.090 |
Why?
|
Patient Care Team | 2 | 2018 | 2510 | 0.090 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 7788 | 0.090 |
Why?
|
Antitubercular Agents | 1 | 2018 | 1374 | 0.090 |
Why?
|
Heart Arrest | 1 | 2020 | 1503 | 0.090 |
Why?
|
Editorial Policies | 1 | 2014 | 457 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2017 | 2433 | 0.080 |
Why?
|
Jugular Veins | 2 | 2008 | 211 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2016 | 2364 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2015 | 1438 | 0.080 |
Why?
|
Radial Artery | 2 | 2008 | 197 | 0.080 |
Why?
|
Laboratories | 1 | 2012 | 461 | 0.080 |
Why?
|
Cross-Sectional Studies | 6 | 2014 | 25860 | 0.080 |
Why?
|
Hospital-Patient Relations | 1 | 2008 | 17 | 0.080 |
Why?
|
Immunity | 1 | 2015 | 998 | 0.080 |
Why?
|
Pulmonary Ventilation | 2 | 2007 | 371 | 0.080 |
Why?
|
Hemodiafiltration | 1 | 2008 | 18 | 0.080 |
Why?
|
Poverty | 1 | 2020 | 2682 | 0.080 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2008 | 146 | 0.080 |
Why?
|
Neoplasms | 4 | 2018 | 22019 | 0.070 |
Why?
|
Heart Rate | 3 | 2015 | 4165 | 0.070 |
Why?
|
Students | 1 | 2018 | 1718 | 0.070 |
Why?
|
Decision Making | 2 | 2014 | 3920 | 0.070 |
Why?
|
Medical Records | 1 | 2013 | 1406 | 0.070 |
Why?
|
Acclimatization | 1 | 2007 | 112 | 0.070 |
Why?
|
Young Adult | 10 | 2020 | 58483 | 0.070 |
Why?
|
Baroreflex | 1 | 2008 | 148 | 0.070 |
Why?
|
Demography | 1 | 2012 | 1648 | 0.070 |
Why?
|
Attitude to Death | 1 | 2010 | 402 | 0.070 |
Why?
|
Hematinics | 1 | 2010 | 281 | 0.070 |
Why?
|
Patient Rights | 1 | 2007 | 125 | 0.070 |
Why?
|
Diuretics | 3 | 2015 | 612 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39216 | 0.070 |
Why?
|
Nursing Staff, Hospital | 1 | 2010 | 344 | 0.070 |
Why?
|
Altitude | 1 | 2007 | 158 | 0.070 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2012 | 709 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2250 | 0.070 |
Why?
|
Environmental Exposure | 2 | 2018 | 4389 | 0.070 |
Why?
|
Observation | 1 | 2008 | 311 | 0.070 |
Why?
|
Cause of Death | 3 | 2017 | 3721 | 0.070 |
Why?
|
Skin Diseases | 1 | 2015 | 1091 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2018 | 3802 | 0.070 |
Why?
|
Acute Disease | 3 | 2012 | 7262 | 0.070 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2009 | 250 | 0.070 |
Why?
|
Pancreatitis | 1 | 2013 | 1100 | 0.070 |
Why?
|
User-Computer Interface | 1 | 2013 | 1402 | 0.070 |
Why?
|
Health Promotion | 1 | 2018 | 2204 | 0.070 |
Why?
|
Hyperoxia | 1 | 2007 | 249 | 0.060 |
Why?
|
Erythropoietin | 1 | 2010 | 720 | 0.060 |
Why?
|
Valproic Acid | 1 | 2008 | 442 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 10333 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1914 | 0.060 |
Why?
|
Predictive Value of Tests | 7 | 2016 | 15264 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2015 | 2694 | 0.060 |
Why?
|
Dermatology | 1 | 2015 | 912 | 0.060 |
Why?
|
Anemia | 1 | 2014 | 1509 | 0.060 |
Why?
|
Education, Medical | 1 | 2016 | 1727 | 0.060 |
Why?
|
Prevalence | 4 | 2016 | 15641 | 0.060 |
Why?
|
Health Care Rationing | 1 | 2007 | 434 | 0.060 |
Why?
|
Antimanic Agents | 1 | 2008 | 520 | 0.060 |
Why?
|
Adenoviridae | 2 | 1998 | 1084 | 0.060 |
Why?
|
Survival Analysis | 2 | 2018 | 10185 | 0.060 |
Why?
|
Brazil | 2 | 2018 | 1211 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3236 | 0.060 |
Why?
|
Computer Simulation | 2 | 2016 | 6195 | 0.060 |
Why?
|
Periodicals as Topic | 1 | 2014 | 1469 | 0.050 |
Why?
|
Leg Ulcer | 1 | 2003 | 69 | 0.050 |
Why?
|
Oxygen | 3 | 2012 | 4188 | 0.050 |
Why?
|
Gram-Positive Bacteria | 1 | 2014 | 178 | 0.050 |
Why?
|
Massachusetts | 1 | 2016 | 8788 | 0.050 |
Why?
|
Air Pollutants | 1 | 2017 | 2841 | 0.050 |
Why?
|
Disease Progression | 2 | 2017 | 13479 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12522 | 0.050 |
Why?
|
Ventricular Function, Left | 1 | 2015 | 3854 | 0.050 |
Why?
|
Pyoderma Gangrenosum | 1 | 2003 | 82 | 0.050 |
Why?
|
Developing Countries | 1 | 2015 | 2876 | 0.050 |
Why?
|
Clinical Competence | 1 | 2018 | 4776 | 0.050 |
Why?
|
Neutrophils | 1 | 2015 | 3767 | 0.050 |
Why?
|
Prospective Studies | 5 | 2019 | 54204 | 0.050 |
Why?
|
Echinocandins | 1 | 2011 | 51 | 0.050 |
Why?
|
Lipopeptides | 1 | 2011 | 73 | 0.050 |
Why?
|
Blood Flow Velocity | 3 | 2010 | 1371 | 0.050 |
Why?
|
Models, Biological | 1 | 2017 | 9466 | 0.050 |
Why?
|
Fluconazole | 1 | 2011 | 155 | 0.040 |
Why?
|
Employment | 1 | 2007 | 1111 | 0.040 |
Why?
|
Homeostasis | 2 | 2008 | 3304 | 0.040 |
Why?
|
Leukocyte Count | 2 | 2015 | 1599 | 0.040 |
Why?
|
Social Class | 2 | 2020 | 2005 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8055 | 0.040 |
Why?
|
European Union | 1 | 2020 | 156 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7790 | 0.040 |
Why?
|
Receptors, Vitronectin | 1 | 1998 | 48 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2092 | 0.040 |
Why?
|
Wavelet Analysis | 1 | 2018 | 55 | 0.040 |
Why?
|
Expert Systems | 1 | 2018 | 79 | 0.040 |
Why?
|
Hepatic Encephalopathy | 1 | 2020 | 142 | 0.040 |
Why?
|
Research Design | 1 | 2014 | 6168 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2018 | 21988 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2852 | 0.040 |
Why?
|
Candida albicans | 1 | 2011 | 377 | 0.040 |
Why?
|
Models, Organizational | 1 | 2001 | 545 | 0.040 |
Why?
|
Clinical Alarms | 1 | 2018 | 61 | 0.040 |
Why?
|
Receptors, Virus | 2 | 1998 | 639 | 0.040 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2010 | 279 | 0.040 |
Why?
|
Therapeutics | 1 | 2018 | 114 | 0.040 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 694 | 0.040 |
Why?
|
Enterovirus | 1 | 1998 | 66 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15672 | 0.040 |
Why?
|
Chronic Disease | 1 | 2012 | 9282 | 0.040 |
Why?
|
Hospitalists | 1 | 2001 | 295 | 0.040 |
Why?
|
Spain | 1 | 2018 | 486 | 0.040 |
Why?
|
Taiwan | 1 | 2018 | 502 | 0.040 |
Why?
|
Clinical Coding | 1 | 2018 | 181 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5880 | 0.030 |
Why?
|
Antifungal Agents | 1 | 2011 | 745 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2017 | 2750 | 0.030 |
Why?
|
Medically Underserved Area | 1 | 2018 | 258 | 0.030 |
Why?
|
Greece | 1 | 2016 | 336 | 0.030 |
Why?
|
Overweight | 2 | 2019 | 2420 | 0.030 |
Why?
|
Colombia | 1 | 2016 | 272 | 0.030 |
Why?
|
Risk | 2 | 2020 | 9623 | 0.030 |
Why?
|
England | 1 | 2017 | 525 | 0.030 |
Why?
|
Programming Languages | 1 | 2016 | 128 | 0.030 |
Why?
|
State Medicine | 1 | 2017 | 213 | 0.030 |
Why?
|
Mongolia | 1 | 2015 | 92 | 0.030 |
Why?
|
Thinness | 1 | 2019 | 491 | 0.030 |
Why?
|
Hypertension | 1 | 2015 | 8594 | 0.030 |
Why?
|
Pregnancy | 1 | 2017 | 29658 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10747 | 0.030 |
Why?
|
Pancreas, Artificial | 1 | 2015 | 54 | 0.030 |
Why?
|
Cities | 1 | 2017 | 538 | 0.030 |
Why?
|
Death | 1 | 2019 | 677 | 0.030 |
Why?
|
Mexico | 1 | 2016 | 755 | 0.030 |
Why?
|
Respiratory Mechanics | 2 | 2008 | 698 | 0.030 |
Why?
|
Incidence | 3 | 2020 | 21336 | 0.030 |
Why?
|
Acid-Base Imbalance | 1 | 2013 | 41 | 0.030 |
Why?
|
Rural Health | 1 | 2015 | 299 | 0.030 |
Why?
|
Microscopy | 1 | 2018 | 880 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 730 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2018 | 804 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2014 | 210 | 0.030 |
Why?
|
Adolescent | 4 | 2020 | 87560 | 0.030 |
Why?
|
Commerce | 1 | 2018 | 604 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2016 | 641 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2018 | 787 | 0.030 |
Why?
|
Focus Groups | 1 | 2018 | 1367 | 0.030 |
Why?
|
Program Development | 1 | 2018 | 1295 | 0.020 |
Why?
|
International Cooperation | 1 | 2018 | 1436 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2018 | 989 | 0.020 |
Why?
|
Uganda | 1 | 2016 | 1326 | 0.020 |
Why?
|
Brain | 2 | 2008 | 26863 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2018 | 1488 | 0.020 |
Why?
|
Perception | 1 | 2018 | 1189 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2016 | 907 | 0.020 |
Why?
|
Patient Selection | 2 | 2016 | 4269 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2012 | 253 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 2019 | 1328 | 0.020 |
Why?
|
Platelet Count | 1 | 2013 | 776 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14652 | 0.020 |
Why?
|
Nursing Methodology Research | 1 | 2010 | 64 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2016 | 1252 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2010 | 6649 | 0.020 |
Why?
|
Visitors to Patients | 1 | 2010 | 36 | 0.020 |
Why?
|
Polypharmacy | 1 | 2013 | 307 | 0.020 |
Why?
|
Geriatric Nursing | 1 | 2010 | 39 | 0.020 |
Why?
|
gamma-Glutamyltransferase | 1 | 2010 | 144 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3804 | 0.020 |
Why?
|
Dyspnea | 1 | 2017 | 1352 | 0.020 |
Why?
|
Phosphates | 1 | 2013 | 771 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1998 | 3377 | 0.020 |
Why?
|
Natriuretic Peptide, C-Type | 1 | 2008 | 18 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2322 | 0.020 |
Why?
|
Muscle Tonus | 1 | 2008 | 82 | 0.020 |
Why?
|
Leadership | 1 | 2018 | 1368 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2698 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6496 | 0.020 |
Why?
|
Obesity, Morbid | 1 | 2019 | 1277 | 0.020 |
Why?
|
Patient Advocacy | 1 | 2010 | 358 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12268 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8469 | 0.020 |
Why?
|
Cerebral Veins | 1 | 2008 | 154 | 0.020 |
Why?
|
Delirium | 1 | 2018 | 1653 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2010 | 866 | 0.020 |
Why?
|
Respiration | 1 | 2012 | 1648 | 0.020 |
Why?
|
Temperature | 1 | 2012 | 2222 | 0.020 |
Why?
|
Placebo Effect | 1 | 2010 | 511 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2012 | 1327 | 0.020 |
Why?
|
Cerebral Arteries | 1 | 2008 | 490 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7380 | 0.020 |
Why?
|
Inpatients | 1 | 2017 | 2580 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2920 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2010 | 742 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2168 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1676 | 0.010 |
Why?
|
Creatinine | 1 | 2010 | 1907 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2015 | 2775 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2008 | 974 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5876 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8434 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2008 | 1483 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7346 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4898 | 0.010 |
Why?
|
Electrocardiography | 1 | 2015 | 6400 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1998 | 5131 | 0.010 |
Why?
|
Qualitative Research | 1 | 2010 | 2940 | 0.010 |
Why?
|
Adenovirus E2 Proteins | 1 | 1998 | 8 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2008 | 2142 | 0.010 |
Why?
|
Family | 1 | 2010 | 3189 | 0.010 |
Why?
|
Thymidine Kinase | 1 | 1998 | 286 | 0.010 |
Why?
|
Ganciclovir | 1 | 1998 | 252 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1998 | 575 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1998 | 871 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 1998 | 898 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2010 | 12386 | 0.010 |
Why?
|
Gene Expression | 2 | 1998 | 7593 | 0.010 |
Why?
|
CHO Cells | 1 | 1998 | 1389 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1998 | 1532 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1998 | 1792 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1998 | 1993 | 0.010 |
Why?
|
Integrins | 1 | 1998 | 840 | 0.010 |
Why?
|
Cricetinae | 1 | 1998 | 2427 | 0.010 |
Why?
|
Mucin-1 | 1 | 1998 | 539 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1998 | 2262 | 0.010 |
Why?
|
Species Specificity | 1 | 1998 | 2412 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2755 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 1998 | 1204 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 13284 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4171 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 1998 | 1827 | 0.010 |
Why?
|
DNA, Viral | 1 | 1998 | 2195 | 0.010 |
Why?
|
Cell Division | 1 | 1998 | 4463 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6131 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2008 | 5076 | 0.010 |
Why?
|
Transfection | 1 | 1998 | 5783 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2003 | 12964 | 0.000 |
Why?
|
Hematopoietic Stem Cells | 1 | 1998 | 3390 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13456 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 17629 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1998 | 12774 | 0.000 |
Why?
|
Mice | 1 | 1998 | 81138 | 0.000 |
Why?
|
Animals | 1 | 1998 | 167838 | 0.000 |
Why?
|